Sanofi's dis­tri­b­u­tion deals; As­traZeneca to sup­ply US and Chi­na in­de­pen­dent­ly; Mer­ck KGaA ex­pands in Chi­na

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial up­dates on new builds, col­lab­o­ra­tions, re­calls and more.

Sanofi has se­cured three deals this week to sup­ply its med­i­cines in In­dia and Ko­rea. On Wednes­day, Dr Red­dy Lab­o­ra­to­ries an­nounced it will dis­trib­ute sev­en of Sanofi’s vac­cines in In­dia, a day af­ter In­di­an man­u­fac­tur­er Cipla said it will lo­cal­ly dis­trib­ute six of Sanofi’s cen­tral ner­vous sys­tem prod­ucts. Al­so on Tues­day, Sanofi un­veiled a part­ner­ship with SK Bio­science to dis­trib­ute five of its vac­cines in Ko­rea.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER